NCT06227949View on ClinicalTrials.gov

FSH and LH Versus FSH Alone for Ovarian Stimulation in Non-hormone Sensitive Onco-fertility Patients

PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

140

Participants

Timeline

Start Date

February 29, 2024

Primary Completion Date

December 31, 2029

Study Completion Date

December 31, 2031

Conditions

Fertility Preservation

Interventions

DRUG

Luveris

Patients will self-administer a subcutaneous injection of Luveris in addition to Gonal-F (FSH) daily until a pre-set criteria to trigger ovulation is reached.